Packaging Configuration. Within five (5) days after the Effective Date, Salix shall supply ▇▇▇▇▇▇ with Salix’s labeling for the Branded Product. Within fourteen (14) days after ▇▇▇▇▇▇’▇ receipt of such labeling, ▇▇▇▇▇▇ shall provide to Salix proposed camera ready artwork for the labeling and packaging for the Generic Product which shall be consistent with the labeling and packaging of the Branded Product; provided that the labeling and packaging for the Generic Product shall have appropriate references to ▇▇▇▇▇▇ and the NDC Numbers obtained pursuant to Section 2.7 and no reference to the Trademark. The labeling and packaging for the Generic Product shall be subject to the prior approval of Salix, which approval shall not be unreasonably withheld or delayed. Salix shall only be obligated to supply to ▇▇▇▇▇▇ Generic Product in the packaging configurations set forth in Exhibit ▇. ▇▇▇▇▇▇ shall be solely responsible for the content of all labeling and packaging print copy and ▇▇▇▇▇▇ shall ensure that all such labeling and packaging print copy complies with all Applicable Laws. Any changes to the packaging and labeling of the Generic Product requested by ▇▇▇▇▇▇ shall require the prior written consent of Salix, which approval shall not be unreasonably withheld or delayed. If Salix consents to such changes, such changes shall be effected at ▇▇▇▇▇▇’▇ sole cost and expense. [*] Confidential treatment requested; certain information omitted and filed separately with the SEC.
Appears in 3 contracts
Sources: Supply and Distribution Agreement, Supply and Distribution Agreement (Salix Pharmaceuticals LTD), Supply and Distribution Agreement (Salix Pharmaceuticals LTD)